Article

The Template, Not the Exception: Ojemda and the Self‐Confirming Logic of the Joint Clinical Assessment

2026-06-25

Abstract excerpt

The Joint Clinical Assessment (JCA) report on tovorafenib (Ojemda), the first assessment of an orphan oncology medicinal product completed under Regulation (EU) 2021/2282 [1], conformed closely to predictions made across our earlier work. This Perspective argues that the outcome was foreseeable from the framework’s design rather than from any feature of the product. We characterise the JCA as an audit that confron...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: b6a6c7cd-8002-5189-9249-8b23fadf1788
DOI: 10.20944/preprints202606.1824.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

The Template, Not the Exception: Ojemda and the Self‐Confirming Logic of the Joint Clinical AssessmentDOI 10.20944/preprints202606.1824.v1Read

Data quality as the missing translational layer in computational drug repurposingSemantic proximity Read

Annotations to Structure a Systematic Review: Methodological Update and Key Principles Using the S0–S3 FlowSemantic proximity Read

Does The Reformed Cancer Drug Fund Generate Evidence On Effectiveness? A Cross-sectional Analysis On Publicly Accessible DocumentationSemantic proximity Read

Disagreement as a signal: an auditable dual-LLM and human-arbitrated workflow for methodological quality assessment in preclinical complex-intervention evidenceSemantic proximity Read

Assessing the Secondary Use and Scientific Impact of Shared Clinical Trial Data: A Cross-Sectional Study of Clinical Trials Shared on the YODA Project PlatformSemantic proximity Read

How far can AI help with assessing the trustworthiness of clinical trial publications? Review of concepts, methods, and questions.Semantic proximity Read

The Adverse Event Atlas and Signal Consensus Index: A Multi-Source Pharmacovigilance PlatformSemantic proximity Read

Systematic post-publication accuracy assessment in medical educational content: development and pilot validation of a five-category taxonomic frameworkSemantic proximity Read

The Current Landscape of Clinical TrialsSemantic proximity Read

How the HTAR will contribute to a value-based decision making for medicinal products across the EUSemantic proximity Read

Agent-Driven Validation of Oncology Therapeutic TargetsSemantic proximity Read

A Prospective Comparative Evaluation of Automatic Trial Matching Tools in a Molecular Tumor BoardSemantic proximity Read